Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €2.93 EUR
Change Today +0.072 / 2.52%
Volume 0.0
TIJ On Other Exchanges
TIJ is not on other exchanges.
As of 2:18 AM 10/7/15 All times are local (Market data is delayed by at least 15 minutes).

teijin ltd (TIJ) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/22/15 - €3.67
52 Week Low
10/17/14 - €1.72
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TEIJIN LTD (TIJ)

Related News

No related news articles were found.

teijin ltd (TIJ) Related Businessweek News

No Related Businessweek News Found

teijin ltd (TIJ) Details

Teijin Limited provides solutions to transportation, information and electronics, safety and protection, environment and energy, and healthcare areas worldwide. The company’s Advanced Fibers and Composites segment offers para-aramid, meta-aramid, polyester, and polyethylene naphthalate (PEN) fibers; synthetic leather; carbon fibers and intermediate materials; carbon fiber reinforced composites; and flame-resistant fibers. Its Electronics Materials and Performance Polymer Products segment provides polycarbonate (PC) resins, PC/ABS and PC/AS polymer alloys, PEN resins, polyethylene terephthalate (PET) resins, polybutylene naphthalete resins, bromine series flame retardants, PET and PEN films, processed films, monomers, and polymers. The company’s Healthcare segment offers Bonalon and Onealfa for the treatment of osteoporosis; Synvisc to treat knee osteoarthritis pain; sonic accelerated fracture healing systems; Mucosolvan, an expectorant; and Alvesco, an inhaled corticosteroid agent for asthma. This segment also provides oxygen concentrators for home oxygen therapy; continuous positive airway pressure units; NIP NASAL, a non-invasive positive pressure ventilator; AutoSet CS, an adaptive servo-ventilator; Feburic to treat hyperuricemia and gout; Tricor for hyperlipidemia; and Venilon for Intravenous immunoglobulin preparation. Its Trading and Retail segment sells and trades fibrous raw material, apparel, industrial materials, and performance polymer products. The company also offers IT services in the healthcare field, Web-based enterprise resource planning, and digital content management services; content distribution services for mobile phones and smartphones, and e-commerce services; and polyester raw materials and polymerization services. Teijin Limited was founded in 1918 and is headquartered in Osaka, Japan.

15,780 Employees
Last Reported Date: 06/24/15
Founded in 1918

teijin ltd (TIJ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

teijin ltd (TIJ) Key Developments

Teijin Announces Changes in Advisory Board Members

Teijin Ltd. announced the changes in the members of its advisory board. Thomas M. Connelly, Jr., Executive Director/CEO, American Chemical Society, will become a new member of the board on October 1, 2015. John W. Himes, former Senior Vice President, DuPont, is scheduled to retire from the board on September 30, 2015.

Teijin Ltd., Q1 2016 Earnings Call, Jul 31, 2015

Teijin Ltd., Q1 2016 Earnings Call, Jul 31, 2015

Teijin Ltd. Provides Dividend Guidance for the First Half and Full Year of Fiscal 2016; Provides Consolidated Earnings Guidance for the First Half Ending September 30, 2015; Revised Consolidated Earnings Guidance for the Full Year of Fiscal 2016; Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Reports Impairment Loss for the First Quarter Ended June 30, 2015

Teijin Ltd. provided dividend guidance for the first half and full year of Fiscal 2016. For the first half, the company expects to pay dividend of JPY 3 per share against JPY 2 per share paid a year ago. For the year 2015, the company expects to pay dividend of JPY 3 per share against JPY 2 per share paid a year ago. The annual dividend is expected to be JPY 6 per share. The company reported consolidated earnings results for the first quarter ended June 30, 2015. For the year, the consolidated net sales of JPY 192,565 million against JPY 181,858 million a year ago. Operating income was JPY 16,412 million against JPY 4,813 million a year ago. Ordinary income was JPY 17,977 million against JPY 4,652,000 a year ago. Income before income taxes was JPY 16,685 million against JPY 3,876 million a year ago. Profit attributable to the owners of the parent was JPY 11,190 million or JPY 10.33 per share against JPY 1,648 million or JPY 1.67 per share a year ago. CapEx was JPY 6.7 billion against JPY 6.2 billion a year ago. Cash flow from operating activities was JPY 12.5 billion against JPY 4.8 billion a year ago. CapEX for tangible assets is JPY 6.1 billion. EBITDA was JPY 25.9 billion against JPY 15.9 billion a year ago. For the fiscal 2016, the company now expects to report consolidated net sales of JPY 810.0 billion, down from initial forecast of JPY 825.0 billion, which was announced on May 8, 2015, as well as operating income of JPY 53.0 billion, ordinary income of JPY 53.0 billion and profit attributable to owners of parent of JPY 30.0 billion, up from initial forecasts of JPY 47.5 billion, JPY 47.5 billion and JPY 25.0 billion, respectively, thereby achieving the relevant targets set out in revised medium-term management plan for fiscal 2016 a year ahead of schedule. The company expects JPY 30.52 per share. CAPEX is expected to be JPY 44 billion. Depreciation & amortization is expected to be JPY 40 billion. CAPEX for tangible assets is expected to be JPY 41.3 billion. ROA is expected to be 6.3%, ROE is expected to be 10%. Operating margin is expected to be 6.5%. EBITDA is expected to be JPY 93 billion. For the first half ending September 30, 2015, the company expects net sales to be JPY 390,000 million, operating income of JPY 28,000 million and ordinary income of JPY 28,000 million, profit attributable to owners of the parent of JPY 18,000 million or JPY 18.31 per share. For the first quarter, the company reported impairment loss of JPY 0.482 million against JPY 0.210 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TIJ:GR €2.93 EUR +0.072

TIJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celanese Corp $64.62 USD +1.41
Corbion NV €20.93 EUR -0.015
LANXESS AG €44.16 EUR +0.213
Mitsui Chemicals Inc ¥434.00 JPY +25.00
Trinseo SA $29.83 USD +1.39
View Industry Companies

Industry Analysis


Industry Average

Valuation TIJ Industry Range
Price/Earnings 100.0x
Price/Sales 0.5x
Price/Book 1.3x
Price/Cash Flow 48.5x
TEV/Sales 0.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEIJIN LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at